Sep 29, 2010
Hi, I am 49 years old.I was diagnosed with hiv and hep c in fll of 2000. I began ttreatment in jan of 2001 with combivir and viracept.Since then I have been undetectable. the only side affect I can see in these past years is faciel wasting.Reciently my doctor sugested that I change my medications to Rayataz,Norvir and Truvada.Is this a smart choice? What are the risks. Thanks....
Response from Dr. McGowan
Thanks for your question.
It is sometimes hard to think about changing meds when their main effect is working fine...keeping the virus undetectable. But sometimes the side effects may be important to making a change. Changing from an unboosted PI (viracept) or a boosted one (norvir + reyataz) is a stronger option for sustained control of the virus. The zidovudine in combivir has certainly been associated with facial waisting and a switch may keep it from getting worse, but some studies indicate that after being on meds for 3+ years it may not get much better. Of course a change may come with new side effects but since there is no drug resistance in the background substitutions could be made more safely.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- What Would Happen If You Had Sex With Someone That Had Genital Warts?
- What Percent Of Americans Have Herpes?
- What Is Skin Herpes?
- What Causes Genital Warts To Come Back?
- What Are The Chances Of Getting Herpes Or Warts From A Safe Exposure With A Prostitute?
- Ways Other Than Sex To Get Herpes
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.